NF-κB-dependent transcriptional activation in lung carcinoma cells by farnesol involves p65/RelA(Ser276) phosphorylation via the MEK-MSK1 signaling pathway

Journal of Biological Chemistry

Volumn 283, Issue 24, 2008, Pages 16391-16399

  Joung, Hyuck Joo ^a   Jetten, Anton M ^a  

^a NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL ORGANS; CHEMICAL REACTIONS; ELECTRIC LOAD MANAGEMENT; ELECTRIC RESISTANCE; ESTERS; GENE EXPRESSION; GENES; TRANSCRIPTION;

CAFFEIC ACID PHENETHYL ESTERS; ER STRESSES; FARNESOL; HUMAN LUNGS; IMMUNE RESPONSES; INFLAMMATORY GENES; LUNG CARCINOMATA; OVEREXPRESSION; SIGNALING PATHWAYS; TRANSACTIVATION; TRANSCRIPTIONAL ACTIVATIONS; TRANSCRIPTIONAL ACTIVITIES;

PHOSPHORYLATION;

1,4 DIAMINO 1,4 BIS(2 AMINOPHENYLTHIO) 2,3 DICYANOBUTADIENE; CHEMOKINE; CYCLOOXYGENASE 2; FARNESOL; I KAPPA B ALPHA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 1ALPHA; INTERLEUKIN 6; MITOGEN ACTIVATED PROTEIN KINASE KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE KINASE 2; N [2 (4 BROMOCINNAMYLAMINO)ETHYL] 5 ISOQUINOLINESULFONAMIDE; PROTEIN CXCL3; SERINE; SYNAPTOTAGMIN I; TRANSCRIPTION FACTOR RELA; UNCLASSIFIED DRUG; I KAPPA B; MAP2K2 PROTEIN, HUMAN; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; MITOGEN AND STRESS ACTIVATED PROTEIN KINASE 1; MITOGEN AND STRESS-ACTIVATED PROTEIN KINASE 1; NF KAPPAB INHIBITOR ALPHA; NF-KAPPAB INHIBITOR ALPHA; S6 KINASE;

ARTICLE; CARCINOMA CELL; CONTROLLED STUDY; ENDOPLASMIC RETICULUM STRESS; GENE EXPRESSION; GENE INDUCTION; GENE OVEREXPRESSION; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; LUNG CARCINOMA; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION; GENE EXPRESSION REGULATION; LUNG TUMOR; METABOLISM; PATHOLOGY; TRANSACTIVATION; TUMOR CELL LINE;

CELL LINE, TUMOR; FARNESOL; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; I-KAPPA B PROTEINS; LUNG NEOPLASMS; MAP KINASE KINASE 1; MAP KINASE KINASE 2; MITOGEN-ACTIVATED PROTEIN KINASE 1; MITOGEN-ACTIVATED PROTEIN KINASE 3; NF-KAPPA B; RIBOSOMAL PROTEIN S6 KINASES, 90-KDA; SIGNAL TRANSDUCTION; TRANS-ACTIVATION (GENETICS); TRANSCRIPTION FACTOR RELA;

EID: 47749092820     PISSN: 00219258     EISSN: 1083351X     Source Type: Journal    
DOI: 10.1074/jbc.M800945200     Document Type: Article

References (51)

1. Goldstein, J. L., and Brown, M. S. (1990) Nature 343, 425-430
2. Edwards, P. A., and Ericsson, J. (1999) Annu. Rev. Biochem. 68, 157-185
3. Endres, M., and Laufs, U. (2004) Stroke 35, 2708-2711
4. Hanley, K., Komuves, L. G., Ng, D. C., Schoonjans, K., He, S. S., Lau, P., Bikle, D. D., Williams, M. L., Elias, P. M., Auwerx, J., and Feingold, K. R. (2000) J. Biol. Chem. 275, 11484-11491
5. Rioja, A., Pizzey, A. R., Marson, C. M., and Thomas, N. S. (2000) FEBS Lett. 467, 291-295
6. Bifulco, M. (2005) Life Sci. 77, 1740-1749
7. Miquel, K., Pradines, A., and Favre, G. (1996) Biochem. Biophys. Res. Commun. 225, 869-876
8. Wright, M. M., Henneberry, A. L., Lagace, T. A., Ridgway, N. D., and McMaster, C. R. (2001) J. Biol. Chem. 276, 25254-25261
9. Mo, H., and Elson, C. E. (2004) Exp. Biol. Med. (Maywood) 229, 567-585
10. Ong, T. P., Heidor, R., de Conti, A., Dagli, M. L., and Moreno, F. S. (2006) Carcinogenesis 27, 1194-1203
11. Bailey, H. H., Attia, S., Love, R. R., Fass, T., Chappell, R., Tutsch, K., Harris, L., Jumonville, A., Hansen, R., Shapiro, G. R., and Stewart, J. A. (2008) Cancer Chemother. Pharmacol. 62, 149-157
12. Burke, Y. D., Stark, M. J., Roach, S. L., Sen, S. E., and Crowell, P. L. (1997) Lipids 32, 151-156
13. Burke, Y. D., Ayoubi, A. S., Werner, S. R., McFarland, B. C., Heilman, D. K., Ruggeri, B. A., and Crowell, P. L. (2002) Anticancer Res. 22, 3127-3134
14. Rao, C. V., Newmark, H. L., and Reddy, B. S. (2002) Cancer Detect. Prev. 26, 419-425
15. He, L., Mo, H., Hadisusilo, S., Qureshi, A. A., and Elson, C. E. (1997) J. Nutr. 127, 668-674
16. Crowell, P. L. (1999) J. Nutr. 129, 775S-778S
17. Azzoli, C. G., Miller, V. A., Ng, K. K., Krug, L. M., Spriggs, D. R., Tong, W. P., Riedel, E. R., and Kris, M. G. (2003) Cancer Chemother. Pharmacol. 51, 493-498
18. Hudes, G. R., Szarka, C. E., Adams, A., Ranganathan, S., McCauley, R. A., Weiner, L. M., Langer, C. J., Litwin, S., Yeslow, G., Halberr, T., Qian, M., and Gallo, J. M. (2000) Clin. Cancer Res. 6, 3071-3080
19. Adany, I., Yazlovitskaya, E. M., Haug, J. S., Voziyan, P. A., and Melnykovych, G. (1994) Cancer Lett. 79, 175-179
20. Gibbs, B. S., Zahn, T. J., Mu, Y., Sebolt-Leopold, J. S., and Gibbs, R. A. (1999) J. Med. Chem. 42, 3800-3808
21. Wiseman, D. A., Werner, S. R., and Crowell, P. L. (2007) J. Pharmacol. Exp. Ther. 320, 1163-1170
22. Forman, B. M., Goode, E., Chen, J., Oro, A. E., Bradley, D. J., Perlmann, T., Noonan, D. J., Burka, L. T., McMorris, T., Lamph, W. W., Evans, R. M., and Weinberger, C. (1995) Cell 81, 687-693
23. Taylor, M. M., Macdonald, K., Morris, A. J., and McMaster, C. R. (2005) FEBS J. 272, 5056-5063
24. Lagace, T. A., Miller, J. R., and Ridgway, N. D. (2002) Mol. Cell. Biol. 22, 4851-4862
25. Fairn, G. D., Macdonald, K., and McMaster, C. R. (2007) J. Biol. Chem. 282, 4868-4874
26. Joo, J. H., Liao, G., Collins, J. B., Grissom, S. F., and Jetten, A. M. (2007) Cancer Res. 67, 7929-7936
27. Wu, J., and Kaufman, R. J. (2006) Cell Death Differ. 13, 374-384
28. Szegezdi, E., Logue, S. E., Gorman, A. M., and Samali, A. (2006) EMBO Rep. 7, 880-885
29. Schroder, M., and Kaufman, R. J. (2005) Mutat. Res. 569, 29-63
30. Kim, R., Emi, M., Tanabe, K., and Murakami, S. (2006) Apoptosis 11, 5-13
31. Schreiber, E., Matthias, P., Muller, M. M., and Schaffner, W. (1989) Nucleic Acids Res. 17, 6419
32. Gambichler, T., Skrygan, M., Hyun, J., Bechara, F., Tomi, N. S., Altmeyer, P., and Kreuter, A. (2006) Arch. Dermatol. Res. 298, 139-141
33. Huang, S. J., Schatz, F., Masch, R., Rahman, M., Buchwalder, L., Niven-Fairchild, T., Tang, C., Abrahams, V. M., Krikun, G., and Lockwood, C. J. (2006) J. Reprod. Immunol. 72, 60-73
34. Alique, M., Moreno, V., Kitamura, M., Xu, Q., and Lucio-Cazana, F. J. (2006) Br. J. Pharmacol. 149, 215-225
35. Kim, Y. M., Cao, D., Reed, W., Wu, W., Jaspers, I., Tal, T., Bromberg, P. A., and Samet, J. M. (2007) Cell. Signal. 19, 538-546
36. Chen, L. F., and Greene, W. C. (2004) Nat. Rev. Mol. Cell. Biol. 5, 392-401
37. Vermeulen, L., De Wilde, G., Van Damme, P., Vanden Berghe, W., and Haegeman, G. (2003) EMBO J. 22, 1313-1324
38. Sakurai, H., Chiba, H., Miyoshi, H., Sugita, T., and Toriumi, W. (1999) J. Biol. Chem. 274, 30353-30356
39. Nicklaus, M. C., Neamati, N., Hong, H., Mazumder, A., Sunder, S., Chen, J., Milne, G. W., and Pommier, Y. (1997) J. Med. Chem. 40, 920-929
40. Natarajan, K., Singh, S., Burke, T. R., Jr., Grunberger, D., and Aggarwal, B. B. (1996) Proc. Natl. Acad. Sci. U. S. A. 93, 9090-9095
41. Chen, Y., Feldman, D. E., Deng, C., Brown, J. A., De Giacomo, A. F., Gaw, A. F., Shi, G., Le, Q. T., Brown, J. M., and Koong, A. C. (2005) Mol. Cancer Res. 3, 669-677
42. Kefaloyianni, E., Gaitanaki, C., and Beis, I. (2006) Cell. Signal. 18, 2238-2251
43. Arai, K., Lee, S. R., van Leyen, K., Kurose, H., and Lo, E. H. (2004) J. Neurochem. 89, 232-239
44. Zhuang, S., Yan, Y., Daubert, R. A., Han, J., and Schnellmann, R. G. (2007) Am. J. Physiol. 292, F440-F447
45. Zhuang, S., and Schnellmann, R. G. (2006) J. Pharmacol. Exp. Ther. 319, 991-997
46. Kucharczak, J., Simmons, M. J., Fan, Y., and Gelinas, C. (2003) Oncogene 22, 8961-8982
47. Liou, H. C., and Hsia, C. Y. (2003) BioEssays 25, 767-780
48. Karin, M., and Greten, F. R. (2005) Nat. Rev. Immunol. 5, 749-759
49. Deng, J., Lu, P. D., Zhang, Y., Scheuner, D., Kaufman, R. J., Sonenberg, N., Harding, H. P., and Ron, D. (2004) Mol. Cell. Biol. 24, 10161-10168
50. Wek, R. C., Jiang, H. Y., and Anthony, T. G. (2006) Biochem. Soc. Trans. 34, 7-11
51. Marciniak, S. J., and Ron, D. (2006) Physiol. Rev. 86, 1133-1149